SEOUL, South Korea--(BUSINESS WIRE)--On November 10, a global multimodality CDMO, GenScript ProBio and specialized CAR-T therapy firm Curocell signed a strategic partnership MOU for the production of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results